Dr. Bernard L. Kasten Jr.

• 
  www.crmz.com/Report/ReportPreview.asp?BusinessId=2823 - [Cached Version]
  Published on: 6/15/2008    Last Visited: 6/15/2008  

  Bernard L. Kasten
  Executive Chairman of the Board
  GeneLink Inc.

• 
  www.sec.gov/Archives/edgar/data/1010086/0000950136-06-0 - [Cached Version]
  Published on: 6/30/2006    Last Visited: 7/1/2006  

  Bernard L. Kasten Jr. M.D.(1)
  ...
  Dr. Kasten became Chief Executive Officer in the third quarter of 2004.Dr. Kasten resigned as Chief Executive Officer of SIGA effective as of April 30, 2006.
  ...
  Bernard L. Kasten, Jr., M.D. has been a director of SIGA since May 23, 2003 and was Chief Executive Officer from the third quarter of 2004 through April 30, 2006.Prior to becoming Chief Executive Officer of SIGA and since February 2002, Dr. Kasten has been Vice President, Medical Affairs of medPlus Inc., a healthcare information technology company and a wholly-owned subsidiary of Quest Diagnostics, Inc., a diagnostic testing, information and services company.Since 1975, Dr. Kasten has been a Diplomat of the American Board of Pathology with a sub-specialty certification 1976 in Medical Microbiology.Dr. Kasten,s staff appointments have included service in the Division of Laboratory Services at The Cleveland Clinic; Associate of Pathology and Laboratory Services at the Bethesda Hospital Systems in Cincinnati, Ohio and Chief Laboratory Officer at Quest Diagnostics Incorporated.Dr. Kasten was a founder of Plexus Vaccine Inc., a vaccine company of which SIGA acquired substantially all of the assets in May 2003.Dr. Kasten is an author of ,,Infectious Disease Handbook,, 5th Edition, 2003, Lexi-Comp Inc.

• 
  www.sec.gov/Archives/edgar/data/1010086/0001169232-06-0 - [Cached Version]
  Published on: 3/29/2006    Last Visited: 3/30/2006  

  Bernard L. Kasten Jr. M.D. Director, Chief Executive Officer
  ...
  Bernard L. Kasten Jr., M.D. has been a director of SIGA since May 23, 2003 and became Chief Executive Officer in the third quarter of 2004.Prior to becoming Chief Executive Officer of SIGA and since February 2002,
  
  Dr. Kasten had been Vice President, Medical Affairs of MedPlus Inc., a healthcare information technology company and a wholly-owned subsidiary of Quest Diagnostics, Inc., a diagnostic testing, information and services company.Since 1975, Dr. Kasten has been a Diplomat of the American Board of Pathology with a sub-specialty certification in 1976 in Medical Microbiology.Dr. Kasten's staff appointments have included service in the Division of Laboratory Medicine at The Cleveland Clinic; Associate Director of Pathology and Laboratory Services at the Bethesda Hospital Systems in Cincinnati, Ohio and Chief Laboratory Officer at Quest Diagnostics Incorporated.Dr. Kasten was a founder of Plexus Vaccine Inc., a vaccine company of which SIGA acquired substantially all of the assets in May 2003.Dr. Kasten is an author of "Infectious Disease Handbook" 5th Edition, 2003, Lexi-Comp Inc.

• 
  www.whispersonwallstreet.com/NASDAQbuzz.htm - [Cached Version]
  Published on: 8/22/2008    Last Visited: 8/22/2008  

  Bernard L. Kasten, M.D., Former CEO, SIGA Technologies (NASDAQ: SIGA)

• 
  www.sec.gov/Archives/edgar/data/941020/0000893220-07-00 - [Cached Version]
  Published on: 4/10/2007    Last Visited: 4/18/2007  

  Dr. Bernard L. Kasten, Jr. Executive Chairman of the Board, Director
  ...
  Dr. Kasten is the Executive Chairman of the Board.Dr. Kasten has been a scientific advisor to the Company since 1999 and a member of the Company's Advisory Committee since 2001.Dr. Kasten is a graduate of Miami University (Oxford Ohio), BA Chemistry 1967, and the Ohio State University College of Medicine MD 1971.His residency was served at the University of Miami, Florida and fellowships at the National Institutes of Health Clinical Center and National Cancer Institute, Bethesda, Maryland.Dr. Kasten is a Diplomat of the American Board of Pathology with Certification in Anatomic and Clinical Pathology with sub-specialty certification in Medical Microbiology.Dr. Kasten is an author of "Infectious Disease Handbook" 1st through 5th Editions 1994-2003 and the "Laboratory Test Handbook" 1st through 4th Editions 1984-1996 published by Lexi-Comp Inc., Hudson, Ohio.Dr. Kasten has been active with the College of American Pathologists (CAP) serving as Chairman of its Publication Committee from 1985-1993, its Management Resources Committee from 1993-1998 and its Chairman Internet Editorial Board from 1999-2003.Dr. Kasten received the College of American Pathologists Presidents Medal Awarded for Outstanding Service in 1989 and the College of American Pathologists Frank W. Hartman Award, in 1993 for Meritorious Service to the College (Founding CAP Today) the organization's highly successful monthly tabloid magazine.Dr. Kasten's professional staff appointments have included the Cleveland Clinic, Northeastern Ohio Universities College of Medicine, the Bethesda Hospitals and Quest Diagnostics.Dr. Kasten served eight years, 1996-2004, at Quest Diagnostics Incorporated [NYSE-DGX], where he was Chief Laboratory Officer; Vice-President of Business Development for Science and Medicine and Vice-President of Medical Affairs of a Quest Diagnostics wholly-owned subsidiary, MedPlus Inc.Dr. Kasten joined SIGA Technologies, Inc. [NASDAQ-SIGA] as a Board of Directors member in May 2003, and accepted the appointment as SIGA's Chief Executive Officer in July of 2004, serving through April 2006.Dr. Kasten is Chairman of the Board of Cleveland Bio Labs Inc. [NASDAQ-CBLI], and also serves on the Board of Directors of SeraCare Life Sciences, CytoLogic Inc, Lexi-Comp Inc, Riggs-Heinrich Media Inc, Highway Composites LLC, Monroeville Industrial Molding Inc, PIPO Inc and Cleveland Bio Labs Inc.
  ...
  For the fiscal year ending December 31, 2007, the Audit Committee will consist of Dr. Kasten and Mr. Hoekstra, each of whom is independent.

• 
  www.sec.gov/Archives/edgar/data/1010086/0001169232-07-0 - [Cached Version]
  Published on: 4/27/2007    Last Visited: 4/28/2007  

  Bernard L. Kasten Jr. M.D. (1) Director, Chief Executive Officer
  ...
  (1) Dr. Kasten became Chief Executive Officer on July 2, 2004.Dr. Kasten resigned as Chief Executive Officer of SIGA effective as of April 30, 2006.Dr. Kasten was a director of SIGA until December 19, 2006.
  ...
  Bernard L. Kasten, Jr., M.D. has been a director of SIGA since May 23, 2003 and was Chief Executive Officer from the third quarter of 2004 through April 30, 2006.Prior to becoming Chief Executive Officer of SIGA and since February 2002, Dr. Kasten has been Vice President, Medical Affairs of MedPlus Inc., a healthcare information technology company and a wholly-owned subsidiary of Quest Diagnostics, Inc., a diagnostic testing, information and services company.Since 1975, Dr. Kasten has been a Diplomat of the American Board of Pathology with a sub-specialty certification 1976 in Medical Microbiology.Dr. Kasten's staff appointments have included service in the Division of Laboratory Services at The Cleveland Clinic; Associate of Pathology and Laboratory Services at the Bethesda Hospital Systems in Cincinnati, Ohio and Chief Laboratory Officer at Quest Diagnostics Incorporated.Dr. Kasten was a founder of Plexus Vaccine Inc., a vaccine company of which SIGA acquired substantially all of the assets in May 2003.Dr. Kasten is also a director of Seracare Life Sciences, Inc.Dr. Kasten is an author of "Infectious Disease Handbook" 5th Edition, 2003, Lexi-Comp Inc.

• 
  www.sec.gov/Archives/edgar/data/1010086/0001169232-04-0 - [Cached Version]
  Published on: 11/22/2004    Last Visited: 2/1/2005  

  THE BOARD OF DIRECTORS RECOMMENDS THAT THE STOCKHOLDERS VOTE "FOR" THE ELECTION (ITEM 1 OF THE ENCLOSED PROXY CARD) OF MR. DRAPKIN, MR. CONSTANCE, DR. KASTEN, DR. MJALLI, DR. OZ, DR. ROSE, MR. SAVAS, DR. WEINER, MS. SLOTKIN AND MR. ANTAL, AS DIRECTORS.
  ...
  Bernard L. Kasten Jr. M.D. Director, Chief Executive Officer
  ...
  Bernard L. Kasten Jr., M.D. has been a director of SIGA since May 23, 2003 and became Chief Executive Officer in the third quarter of 2004.Prior to becoming Chief Executive Officer of SIGA and since February 2002, Dr. Kasten had been Vice President, Medical Affairs of MedPlus Inc., a healthcare information technology company and a wholly-owned subsidiary of Quest Diagnostics, Inc., a diagnostic testing, information and services company.Since 1975, Dr. Kasten has been a Diplomat of the American Board of Pathology with a sub-specialty certification in 1976 in Medical Microbiology.Dr. Kasten's staff appointments have included service in the Division of Laboratory Medicine at The Cleveland Clinic; Associate Director of Pathology and Laboratory Services at the Bethesda Hospital Systems in Cincinnati, Ohio and Chief Laboratory Officer at Quest Diagnostics Incorporated.Dr.
  
  Kasten was a founder of Plexus Vaccine Inc., a vaccine company of which SIGA acquired substantially all of the assets in May 2003.Dr. Kasten is an author of
  ...
  Bernard L. Kasten Jr. M.D. (1) Director, Chief Executive Officer
  ...
  ---------- (1) Dr. Kasten became Chief Executive Officer in the third quarter of 2004.See Director Nominee Information above for additional information
  
  regarding Dr. Kasten.

• 
  www.sec.gov/Archives/edgar/data/1010086/0001169232-03-0 - [Cached Version]
  Published on: 12/5/2003    Last Visited: 12/9/2003  

  Bernard L. Kasten Jr., M.D. Director
  ...
  Bernard L. Kasten Jr., M.D. has been a director of SIGA since May 23, 2003.Since February 2002, Dr. Kasten has been Vice President, Medical Affairs of MedPlus Inc., a healthcare information technology company and a wholly-owned subsidiary of Quest Diagnostics, Inc., a diagnostic testing, information and services company.Since 1975, Dr. Kasten has been a Diplomat of the American Board of Pathology with a sub-specialty certification in 1976 in Medical Microbiology.Dr. Kasten's staff appointments have included service in the Division of Laboratory Medicine at The Cleveland Clinic; Associate Director of Pathology and Laboratory Services at the Bethesda Hospital Systems in Cincinnati, Ohio and Chief Laboratory Officer at Quest Diagnostics Incorporated.Dr. Kasten was a founder of Plexus Vaccine Inc., a vaccine company of which SIGA acquired substantially all of the assets in May 2003.Dr. Kasten is an author of

• 
  www.sec.gov/Archives/edgar/data/1010086/0001169232-03-0 - [Cached Version]
  Published on: 11/7/2003    Last Visited: 11/10/2003  

  Director Bernard L. Kasten Jr., M.D.
  ...
  Bernard L. Kasten Jr., M.D. has been a director of SIGA since May 23, 2003.Since February 2002, Dr. Kasten has been Vice President, Medical Affairs of MedPlus Inc., a healthcare information technology company and a wholly-owned subsidiary of Quest Diagnostics, Inc., a diagnostic testing, information and services company.Since 1975, Dr. Kasten has been a Diplomat of the American Board of Pathology with a sub-specialty certification in 1976 in Medical Microbiology.Dr. Kasten's staff appointments have included service in the Division of Laboratory Medicine at The Cleveland Clinic; Associate Director of Pathology and Laboratory Services at the Bethesda Hospital Systems in Cincinnati, Ohio and Chief Laboratory Officer at Quest Diagnostics Incorporated.Dr. Kasten was a founder of Plexus Vaccine Inc., a vaccine company of which SIGA acquired substantially all of the assets in May 2003.Dr. Kasten is an author of "Infectious Disease Handbook" 5th Edition, 2003, Lexi-Comp Inc.
  ...
  Bernard L. Kasten Jr., M.D. 408,801(14) 4690 Parkway Drive
  ...
  On July 10, 2003, the Board of Directors held a meeting at which Donald G. Drapkin, Thomas E. Constance, Mehmet C. Oz, M.D., Michael A. Weiner, M.D., Eric A. Rose, M.D., Roger Brent, Ph.D., Charles Cantor, Ph.D. and Bernard L. Kasten Jr., M.D. were present either in person or by telephone.
  ...
  The Special Committee consisted of Roger Brent, Ph.D., Charles Cantor, Ph.D., Bernard L. Kasten Jr., M.D., Mehmet C. Oz, M.D., Eric A. Rose.

Page:  1 2 3 4 5